Enhancing nanomedicine efficacy in KPC pancreatic tumors through ketotifen-mediated tumor microenvironment remodeling.

Although, survival improvements in the ketotifen-treated groups did not reach statistical significance at the standard dosing regimen, the therapeutic benefit of ketotifen became more evident when Doxil and PLAD doses were reduced to minimize toxicity.

also in 111,027 other papers